Key Takeaways
- AMD (AMD) shares jumped 6.5% following news of a massive $60 billion AI chip supply agreement with Meta (META).
- Anthropic escalated the AI software war by integrating Claude into Microsoft Excel and PowerPoint, directly challenging Microsoft (MSFT) and OpenAI.
- Bank of England (BoE) officials warned that the disinflation process may be stalling, suggesting a more cautious approach to future interest rate cuts.
- Novo Nordisk (NVO) announced plans to cut U.S. list prices for Ozempic and Wegovy by up to 50%, causing Eli Lilly (LLY) shares to slide 1.2%.
- Federal Reserve Governor Cook stated that AI represents the "most significant reorganization of work in generations," which could temporarily raise the neutral rate of interest.
AI Hardware and Big Tech Expansion
Advanced Micro Devices (AMD) saw its stock price climb 6.5% in early trading after confirming a landmark deal to sell up to $60 billion worth of AI chips to Meta (META). This partnership underscores Meta's aggressive infrastructure build-out as it prepares for a major stablecoin comeback slated for the second half of 2026.
In the software space, Anthropic announced a significant expansion of its Claude AI platform, introducing five new plugins that allow the assistant to work directly across Microsoft Excel and PowerPoint. This move is a direct challenge to Microsoft (MSFT), which has integrated its own Copilot technology across the Office suite. Anthropic also unveiled 10 specialized plugins for industries including investment banking, HR, and design.
Central Bank Caution on Inflation and AI
The Bank of England delivered a hawkish tone today as several officials suggested that the UK's disinflation process might be stalling. BoE Chief Economist Huw Pill noted that underlying inflation remains between 2.5% and 3%, adding that "more work" is needed to reach targets. Governor Andrew Bailey echoed this sentiment, stating that services inflation has not eased as much as the bank had hoped.
In the U.S., Federal Reserve Governor Lisa Cook highlighted the structural shifts caused by artificial intelligence, noting that productivity gains could keep growth strong even if unemployment rises during the transition. Meanwhile, Fed Governor Christopher Waller took a more optimistic view, stating he is not a "doom and gloomer" regarding AI. Waller argued that the technology is a tool that will likely augment rather than displace white-collar work.
Healthcare and Global Market Disruptions
The pharmaceutical sector faced volatility after reports surfaced that Novo Nordisk (NVO) will slash the list prices of its blockbuster GLP-1 drugs, Ozempic and Wegovy, by 50%. The move put immediate pressure on competitor Eli Lilly (LLY), whose shares fell 1.2% on the news. Analysts suggest this price war could significantly alter the margin profiles of the weight-loss drug market.
On the industrial front, Honda (HMC) was forced to suspend operations at its Mexican plant in Guadalajara following a violent "cartel rampage" linked to the killing of a drug lord. In geopolitics, G7 leaders reaffirmed their "unwavering support" for Ukraine, while acknowledging that a lasting peace agreement will ultimately require good-faith negotiations between Ukraine and Russia.
Market Open Summary
U.S. indices opened the session with marginal losses as investors weighed the mixed signals from central bankers against the massive AI hardware deal. The Nasdaq edged down 0.01% to 22,625.65, while the S&P 500 slipped 0.08% to 6,832.29. The Dow Jones Industrial Average saw a minor decline of 10.24 points to trade at 48,793.82.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.